CHINA JO-JO DRUGSTORES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.834 USD | +0.14% |
|
-0.91% | -36.17% |
| Mar. 20 | China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
| Mar. 05 | Top Premarket Gainers | MT |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 34.01 | 75.81 | 59.62 | 46.76 | 13.24 | 91.24 |
| Enterprise Value (EV) 1 | 38.74 | 93.06 | 98.22 | 71.85 | 43.36 | 114.6 |
| P/E ratio | -1.98 x | -81.8 x | -10.1 x | -5.6 x | -4.14 x | -2.16 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.35 x | 0.7 x | 0.51 x | 0.35 x | 0.08 x | 0.61 x |
| EV / Revenue | 0.4 x | 0.87 x | 0.84 x | 0.54 x | 0.26 x | 0.77 x |
| EV / EBITDA | -2.57 x | 116 x | -22.9 x | -10.4 x | -32.3 x | -5.67 x |
| EV / FCF | -6.58 x | -7.76 x | -18.4 x | 24 x | -5.59 x | 18.9 x |
| FCF Yield | -15.2% | -12.9% | -5.44% | 4.17% | -17.9% | 5.28% |
| Price to Book | 2.07 x | 4.17 x | 2.9 x | 1.82 x | 0.55 x | 5.89 x |
| Nbr of stocks (in thousands) | 105 | 121 | 137 | 174 | 174 | 1,018 |
| Reference price 2 | 323.8 | 628.8 | 434.4 | 268.8 | 76.13 | 89.60 |
| Announcement Date | 6/29/18 | 7/1/19 | 7/10/20 | 6/29/21 | 7/28/22 | 6/15/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 96.11 | 107.6 | 117.3 | 133.1 | 164.4 | 148.8 |
| EBITDA 1 | -15.05 | 0.8003 | -4.293 | -6.91 | -1.344 | -20.23 |
| EBIT 1 | -16.44 | -0.8761 | -6.376 | -8.609 | -2.545 | -20.93 |
| Operating Margin | -17.1% | -0.81% | -5.43% | -6.47% | -1.55% | -14.06% |
| Earnings before Tax (EBT) 1 | -16.98 | -1.183 | -6.441 | -8.344 | -2.099 | -20.74 |
| Net income 1 | -17.06 | -0.9263 | -5.813 | -8.12 | -3.192 | -21.14 |
| Net margin | -17.75% | -0.86% | -4.95% | -6.1% | -1.94% | -14.2% |
| EPS 2 | -163.2 | -7.682 | -43.20 | -48.00 | -18.40 | -41.46 |
| Free Cash Flow 1 | -5.887 | -11.99 | -5.345 | 2.998 | -7.76 | 6.047 |
| FCF margin | -6.12% | -11.14% | -4.56% | 2.25% | -4.72% | 4.06% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 6/29/18 | 7/1/19 | 7/10/20 | 6/29/21 | 7/28/22 | 6/15/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 4.72 | 17.2 | 38.6 | 25.1 | 30.1 | 23.3 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -0.3137 x | 21.55 x | -8.994 x | -3.631 x | -22.42 x | -1.154 x |
| Free Cash Flow 1 | -5.89 | -12 | -5.34 | 3 | -7.76 | 6.05 |
| ROE (net income / shareholders' equity) | -74.9% | -7.35% | -36.1% | -38.8% | -13.6% | -107% |
| ROA (Net income/ Total Assets) | -14.6% | -0.75% | -4.63% | -5.23% | -1.5% | -13.3% |
| Assets 1 | 117.1 | 123.9 | 125.6 | 155.3 | 213.4 | 159.5 |
| Book Value Per Share 2 | 156.0 | 151.0 | 150.0 | 148.0 | 138.0 | 15.20 |
| Cash Flow per Share 2 | 126.0 | 77.30 | 118.0 | 127.0 | 106.0 | 15.90 |
| Capex 1 | 1.76 | 7.28 | 1.41 | 0.51 | 0.3 | 0.3 |
| Capex / Sales | 1.83% | 6.77% | 1.2% | 0.38% | 0.18% | 0.2% |
| Announcement Date | 6/29/18 | 7/1/19 | 7/10/20 | 6/29/21 | 7/28/22 | 6/15/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -36.17% | 6.13M | |
| -31.97% | 10.84B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -30.42% | 6.06B | |
| -0.88% | 4.71B | |
| +52.19% | 4.29B | |
| -12.31% | 3.61B | |
| -14.86% | 3.33B | |
| -6.93% | 3.01B |
- Stock Market
- Equities
- CJJD Stock
- Financials China Jo-Jo Drugstores, Inc.
